Management on sanitary inspection behind quality of foodstuff and medicines of the USA approved a drug «edaravone» (edaravone), is able to significantly slow the progressive disease of the Central nervous system, known as BAS (amyotrophic lateral sclerosis).
This is the first drug to combat the disease developed over the last 22 years. It is produced by the Japanese company Mitsubishi Tanabe Pharma’s Not, according to Reuters.
According to clinical studies, six months of applying this medication slows the rate of decline of vital functions of patients by about a third. Up to now for this purpose there was the only drug significantly slows the progression of ALS, is riluzole.
BASS is a slowly progressive, incurable degenerative disease of the Central nervous system in which there is a loss of both upper (motor cortex) and lower (anterior horns of the spinal cord and cranial nerve nuclei) motor neurons that leads to paralysis and subsequent muscle atrophy. The disease was first described in 1869 by the French psychiatrist Jean-Martin Charcot, and was named «Lou Gehrig’s disease».
Usually detect the first signs of als to death is three to five years. Famous theoretical physicist Stephen Hawking (b. in 1942) and guitarist Jason Becker (b. 1969), suffering from this disease are the patients with diagnosed ALS, whose condition eventually stabilized.